Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide and Computerized Psychotherapy for Alcohol Use Disorder
NCT02901041Phase 3Completed
- Start
- Sep 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol use disorder (AUD) comparing Zonisamide + Take Control with Placebo + Take Control (2 arms). Primary endpoints: Average Standard Drinking Units Per Day at Week 12, Percentage of Drinking Days at Week 12 and 2 more. Started Sep 2017; status: completed.
02
Drugs
zonisamide
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02901041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02901041.